Literature DB >> 20457813

Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1.

Xing Du1, Richard J Youle, David J FitzGerald, Ira Pastan.   

Abstract

Pseudomonas exotoxin A (PE) is a bacterial toxin that arrests protein synthesis and induces apoptosis. Here, we utilized mouse embryo fibroblasts (MEFs) deficient in Bak and Bax to determine the roles of these proteins in cell death induced by PE. PE induced a rapid and dose-dependent induction of apoptosis in wild-type (WT) and Bax knockout (Bax(-/-)) MEFs but failed in Bak knockout (Bak(-/-)) and Bax/Bak double-knockout (DKO) MEFs. Also a loss of mitochondrial membrane potential was observed in WT and Bax(-/-) MEFs, but not in Bak(-/-) or in DKO MEFs, indicating an effect of PE on mitochondrial permeability. PE-mediated inhibition of protein synthesis was identical in all 4 cell lines, indicating that differences in killing were due to steps after the ADP-ribosylation of EF2. Mcl-1, but not Bcl-x(L), was rapidly degraded after PE treatment, consistent with a role for Mcl-1 in the PE death pathway. Bak was associated with Mcl-1 and Bcl-x(L) in MEFs and uncoupled from suppressed complexes after PE treatment. Overexpression of Mcl-1 and Bcl-x(L) inhibited PE-induced MEF death. Our data suggest that Bak is the preferential mediator of PE-mediated apoptosis and that the rapid degradation of Mcl-1 unleashes Bak to activate apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457813      PMCID: PMC2897547          DOI: 10.1128/MCB.00813-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   5.069


  43 in total

1.  Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation.

Authors:  Deepak Nijhawan; Min Fang; Elie Traer; Qing Zhong; Wenhua Gao; Fenghe Du; Xiaodong Wang
Journal:  Genes Dev       Date:  2003-06-03       Impact factor: 11.361

2.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

Authors:  Lin Chen; Simon N Willis; Andrew Wei; Brian J Smith; Jamie I Fletcher; Mark G Hinds; Peter M Colman; Catherine L Day; Jerry M Adams; David C S Huang
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

3.  Bak but not Bax is essential for Bcl-xS-induced apoptosis.

Authors:  L Lindenboim; S Kringel; T Braun; C Borner; R Stein
Journal:  Cell Death Differ       Date:  2005-07       Impact factor: 15.828

4.  Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.

Authors:  M C Wei; W X Zong; E H Cheng; T Lindsten; V Panoutsakopoulou; A J Ross; K A Roth; G R MacGregor; C B Thompson; S J Korsmeyer
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

5.  BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak.

Authors:  W X Zong; T Lindsten; A J Ross; G R MacGregor; C B Thompson
Journal:  Genes Dev       Date:  2001-06-15       Impact factor: 11.361

6.  Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

Authors:  E Olsen; M Duvic; A Frankel; Y Kim; A Martin; E Vonderheid; B Jegasothy; G Wood; M Gordon; P Heald; A Oseroff; L Pinter-Brown; G Bowen; T Kuzel; D Fivenson; F Foss; M Glode; A Molina; E Knobler; S Stewart; K Cooper; S Stevens; F Craig; J Reuben; P Bacha; J Nichols
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

7.  Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.

Authors:  David E MacCallum; Jean Melville; Sheelagh Frame; Kathryn Watt; Sian Anderson; Athos Gianella-Borradori; David P Lane; Simon R Green
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

8.  NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.

Authors:  Tsutomu Shimazu; Kurt Degenhardt; Alam Nur-E-Kamal; Junjie Zhang; Takeshi Yoshida; Yonglong Zhang; Robin Mathew; Eileen White; Masayori Inouye
Journal:  Genes Dev       Date:  2007-04-02       Impact factor: 11.361

Review 9.  Apoptotic pathways in tumor progression and therapy.

Authors:  Armelle Melet; Keli Song; Octavian Bucur; Zainab Jagani; Alexandra R Grassian; Roya Khosravi-Far
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

10.  Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis.

Authors:  Jie Han; Leslie A Goldstein; Brian R Gastman; Hannah Rabinowich
Journal:  J Biol Chem       Date:  2006-02-13       Impact factor: 5.157

View more
  40 in total

1.  The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion.

Authors:  Viola Biberacher; Thomas Decker; Madlen Oelsner; Michaela Wagner; Christian Bogner; Burkhard Schmidt; Robert J Kreitman; Christian Peschel; Ira Pastan; Christian Meyer Zum Büschenfelde; Ingo Ringshausen
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 2.  Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Clin Cancer Res       Date:  2011-10-15       Impact factor: 12.531

3.  Killing of resistant cancer cells with low Bak by a combination of an antimesothelin immunotoxin and a TRAIL Receptor 2 agonist antibody.

Authors:  Xing Du; Laiman Xiang; Crystal Mackall; Ira Pastan
Journal:  Clin Cancer Res       Date:  2011-08-03       Impact factor: 12.531

4.  Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.

Authors:  Lina Han; Jeffrey L Jorgensen; Chris Brooks; Ce Shi; Qi Zhang; Graciela M Nogueras González; Antonio Cavazos; Rongqing Pan; Hong Mu; Sa A Wang; Jin Zhou; Gheath Ai-Atrash; Stefan O Ciurea; Mike Rettig; John F DiPersio; Jorge Cortes; Xuelin Huang; Hagop M Kantarjian; Michael Andreeff; Farhad Ravandi; Marina Konopleva
Journal:  Clin Cancer Res       Date:  2017-01-17       Impact factor: 12.531

5.  Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis.

Authors:  Xiu Fen Liu; Laiman Xiang; Qi Zhou; Jean-Philippe Carralot; Marco Prunotto; Gerhard Niederfellner; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

6.  Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy.

Authors:  Hui Wei; Laiman Xiang; Alan S Wayne; Oleg Chertov; David J FitzGerald; Tapan K Bera; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

Review 7.  Immunoconjugates in the management of hairy cell leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Best Pract Res Clin Haematol       Date:  2015-10-09       Impact factor: 3.020

8.  A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene.

Authors:  Hui Wei; Tapan K Bera; Alan S Wayne; Laiman Xiang; Simona Colantonio; Oleg Chertov; Ira Pastan
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

9.  Bcl-2 family proteins and cytoskeleton changes involved in DM-1 cytotoxic effect on melanoma cells.

Authors:  Fernanda Faião-Flores; José Agustín Quincoces Suarez; Vanessa Soto-Cerrato; Margarita Espona-Fiedler; Ricardo Pérez-Tomás; Durvanei Augusto Maria
Journal:  Tumour Biol       Date:  2013-01-23

10.  The insulin receptor negatively regulates the action of Pseudomonas toxin-based immunotoxins and native Pseudomonas toxin.

Authors:  Xiu Fen Liu; David J FitzGerald; Ira Pastan
Journal:  Cancer Res       Date:  2013-01-24       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.